A Novel Process for Obtaining Pinosylvin Using Combinatorial Bioengineering in Escherichia Coli
Overview
Microbiology
Affiliations
Pinosylvin as a bioactive stilbene is of great interest for food supplements and pharmaceuticals development. In comparison to conventional extraction of pinosylvin from plant sources, biosynthesis engineering of microbial cell factories is a sustainable and flexible alternative method. Current synthetic strategies often require expensive phenylpropanoic precursor and inducer, which are not available for large-scale fermentation process. In this study, three bioengineering strategies were described to the development of a simple and economical process for pinosylvin biosynthesis in Escherichia coli. Firstly, we evaluated different construct environments to give a highly efficient constitutive system for enzymes of pinosylvin pathway expression: 4-coumarate: coenzyme A ligase (4CL) and stilbene synthase (STS). Secondly, malonyl coenzyme A (malonyl-CoA) is a key precursor of pinosylvin bioproduction and at low level in E. coli cell. Thus clustered regularly interspaced short palindromic repeats interference (CRISPRi) was explored to inactivate malonyl-CoA consumption pathway to increase its availability. The resulting pinosylvin content in engineered E. coli was obtained a 1.9-fold increase depending on the repression of fabD (encoding malonyl-CoA-ACP transacylase) gene. Eventually, a phenylalanine over-producing E. coli consisting phenylalanine ammonia lyase was introduced to produce the precursor of pinosylvin, trans-cinnamic acid, the crude extraction of cultural medium was used as supplementation for pinosylvin bioproduction. Using these combinatorial processes, 47.49 mg/L pinosylvin was produced from glycerol.
Kim Y, Han J, Choi Y Front Plant Sci. 2024; 15:1342626.
PMID: 38304739 PMC: 10830828. DOI: 10.3389/fpls.2024.1342626.
Sustainable biosynthetic pathways to value-added bioproducts from hydroxycinnamic acids.
Tramontina R, Ciancaglini I, Roman E, Chacon M, Correa T, Dixon N Appl Microbiol Biotechnol. 2023; 107(13):4165-4185.
PMID: 37212882 DOI: 10.1007/s00253-023-12571-8.
Hu Y, Zhang C, Zou L, Zheng Z, Ouyang J Biotechnol Biofuels Bioprod. 2022; 15(1):136.
PMID: 36503554 PMC: 9743564. DOI: 10.1186/s13068-022-02236-5.
Natural Sources and Pharmacological Properties of Pinosylvin.
Bakrim S, Machate H, Benali T, Sahib N, Jaouadi I, El Omari N Plants (Basel). 2022; 11(12).
PMID: 35736692 PMC: 9228742. DOI: 10.3390/plants11121541.
Synthetic Biology-Driven Microbial Production of Resveratrol: Advances and Perspectives.
Feng C, Chen J, Ye W, Liao K, Wang Z, Song X Front Bioeng Biotechnol. 2022; 10:833920.
PMID: 35127664 PMC: 8811299. DOI: 10.3389/fbioe.2022.833920.